Xtane 25 mg Tablets
1000 INR/Bottle
Product Details:
- Dosage Form Tablet
- Salt Composition Exemestane 25 mg
- Indication Breast Cancer
- Enzyme Types Other
- Feature Other
- Ingredients Other
- Application Hormonal Therapy
- Click to View more
X
Xtane 25 mg Tablets Price And Quantity
- 1000 INR/Bottle
- 1 Bottle
Xtane 25 mg Tablets Product Specifications
- Aromatase Inhibitor
- Other
- 1 Years
- White, round biconvex film coated tablets
- Exemestane 25 mg
- Other
- Breast Cancer
- Tablet
- Other
- Hormonal Therapy
- Strong Smell
- Dry Place
Xtane 25 mg Tablets Trade Information
- Cash Advance (CA)
- 7 Days
- All India
Product Description
Technical Specification
- Treatment : Breast Cancer
- Country of Origin : Made in India
- Strength : 25 mg
- Packaging Type : Bottles
- Grade Standard : Medicine Grade
- Medicine Type : Allopathic
- Packaging Size : 30 Tablets
- Form : Tablet
- Manufacturer : Natco
- Composition : Exemestane Tablets
- Brand : Xtane
Aromatase Inhibitor for Targeted Breast Cancer Therapy
Xtane 25 mg Tablets are formulated to address hormone-dependent breast cancer by acting as an aromatase inhibitor. By reducing estrogen production, Exemestane helps slow or halt the growth of cancer cells sensitive to hormones. The medication is an essential component in hormonal therapy regimens for postmenopausal women, recommended solely under medical supervision and by prescription.
Proper Administration and Storage Guidelines
Xtane 25 mg Tablets should be taken orally, as directed by your physician. Consistency with timing enhances effectiveness, and the medication must be stored in a dry place away from moisture to maintain stability over its one-year shelf life. Patients should avoid exposure to excessive heat or humidity. Observing proper storage extends the product's efficacy and safety.
FAQ's of Xtane 25 mg Tablets:
Q: How should Xtane 25 mg Tablets be taken for optimal effectiveness?
A: Xtane 25 mg Tablets are administered orally, once daily after a meal, or as prescribed by your oncologist. Regular daily intake at the same time helps maintain stable medication levels in your system. Always follow your healthcare provider's instructions closely.Q: What is the main benefit of using Xtane 25 mg Tablets in breast cancer treatment?
A: Xtane 25 mg Tablets work as an aromatase inhibitor, significantly lowering estrogen production in postmenopausal women. Reduced estrogen helps slow the progression of hormone-sensitive breast cancer, thereby improving outcomes as part of a comprehensive hormonal therapy plan.Q: When should I start and stop taking Xtane 25 mg Tablets?
A: Your oncologist will determine the appropriate time to start Xtane, typically after surgery or at a specific point during cancer treatment. Continue the medication as long as prescribed and do not stop taking it without consulting your doctor, even if you feel well.Q: Where should I store Xtane 25 mg Tablets to ensure their efficacy?
A: Store Xtane 25 mg Tablets in a cool, dry place away from moisture and direct sunlight. Do not use the medication beyond the indicated one-year shelf life and keep it out of reach of children.Q: What should I do if I notice a strong fermentation smell from the tablets?
A: Xtane 25 mg Tablets may have a noticeable strong smell due to their composition. This is a known characteristic and does not usually affect effectiveness. However, if you observe any changes in color or texture or have concerns, consult your pharmacist or healthcare provider.Q: What is the process for obtaining Xtane 25 mg Tablets in India?
A: Xtane 25 mg Tablets are available by prescription only. After consulting your oncologist and receiving a valid prescription, you can purchase them from authorized pharmacies, dealers, or distributors across India.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicine' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
